EdwinCKingsleyMD

Oncology • Las Vegas, NV

Physician

Join to view full profile

Dr. Kingsley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kingsley's full profile

Already have an account?

Office
3730 S Eastern Ave
Las Vegas, NV 89109
Phone+1 702-952-3400

Fax+1 702-952-3444
Is this information wrong?

Education & Training

University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1980 - 1983
University of Utah School of MedicineClass of 1980

Certifications & Licensure

NV State Medical License 1985 - 2025
AZ State Medical License 1981 - 2020
UT State Medical License 1985 - 1986
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas Start of enrollment: 2013 Jan 16
Terminated
Phase 3
Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Start of enrollment: 2014 Mar 13
Completed
Phase 1, Phase 2
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2018 Nov 01
Completed
Phase 3
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma Start of enrollment: 2017 Oct 04
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator
A Study of SGN-B6A in Advanced Solid Tumors Start of enrollment: 2020 Jun 08
Recruiting
Phase 1
Roles: Contact, Principal Investigator
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma Start of enrollment: 2022 Oct 27
Active, not recruiting
Phase 1
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Genomic landscape of patients in a phase II study of zanubrutinib in ibrutinib- and/or acalabrutinib-intolerant patients with B-cell malignancies.
Xu, L., Shadman, M., Flinn, I., Levy, M., Porter, R., Burke, J., Zafar, S., Cultrera, J., Misleh, J., Kingsley, E., Yimer, H., Freeman, B., Chaudhry, A., Tumula, P., G...> ;Haematologica. 2024 Jan 25
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma.
Pier Luigi Zinzani, Jiří Mayer, Christopher R Flowers, Fontanet Bijou, Ana C De Oliveira, Yuqin Song, Qingyuan Zhang, Michele Merli, Krimo Bouabdallah, Peter Ganly, Hu...> ;Journal of Clinical Oncology. 2023 Nov 20
2 citations
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
Jorge J Castillo, Edwin C Kingsley, Mohit Narang, Habte A Yimer, Constantin A Dasanu, Jason M Melear, Morton Coleman, Charles M Farber, Jonah Shulman, Emily H Mantovan...> ;Ejhaem. 2023 Feb 1
19 citations
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...
Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Syed F Zafar, Jamal Misleh, Edwin C Kingsley, Habte A Yimer, Benjamin Freeman, Subramanya S Rao...> ;The Lancet. Haematology. 2023 Jan 1
6 citations
Cancer survivorship in hematologic malignancies: Lifestyle changes after diagnosis.
Pannaga Malalur, Manas Agastya, Sandhya Wahi-Gururaj, Chad L Cross, Delva Deauna-Limayo, Edwin C Kingsley> ;Cancer Medicine. 2021 Feb 1
88 citations
Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL
Andre Goy, Radhakrishnan Ramchandren, Nilanjan Ghosh, Javier Munoz, David S. Morgan, Nam H. Dang, Mark Knapp, Maria Delioukina, Edwin C. Kingsley, Jerry Ping, Darrin M...> ;Blood. 2019 Sep 26
46 citations
A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma.
Tycel Phillips, Paul M. Barr, Steven I. Park, Kathryn S. Kolibaba, Paolo Caimi, Saurabh Chhabra, Edwin C. Kingsley, Thomas E. Boyd, Robert T. Chen, Anne Sophie Carret,...> ;Investigational New Drugs. 2019 Apr 1
6 citations
Acute Promyelocytic Leukemia
Edwin C. Kingsley, Brian G.M. Durie, Harinder S. Garewal> ;The Western Journal of Medicine. 1987 Mar 1
5 citations
Prolonged survival in patients with treatment-related leukemia.
Edwin C. Kingsley, Brian G.M. Durie> ;Scandinavian Journal of Haematology. 2009 Apr 24
Join now to see all